A Combined Digital and Biomarker Diagnostic Aid for Mood Disorders (the Delta Trial): Protocol for an Observational Study

Olmert T., Cooper J. D., Han S. Y. S., Barton-Owen G., Farrag L., Bell E., ...More

JMIR RESEARCH PROTOCOLS, vol.9, no.8, 2020 (ESCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 9 Issue: 8
  • Publication Date: 2020
  • Doi Number: 10.2196/18453
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, Directory of Open Access Journals
  • Keywords: proteomics, early diagnosis, mood disorders, bipolar disorder, major depressive disorders, BIPOLAR-II-DISORDER, CLINICAL-TRIALS, MENTAL-DISORDERS, EFFICACY TRIALS, DEPRESSION, PREVALENCE, GENERALIZABILITY, BURDEN, FRAMEWORK, IMPACT
  • Middle East Technical University Affiliated: Yes


Background: Mood disorders affect hundreds of millions of people worldwide, imposing a substantial medical and economic burden. Existing diagnostic methods for mood disorders often result in a delay until accurate diagnosis, exacerbating the challenges of these disorders. Advances in digital tools for psychiatry and understanding the biological basis of mood disorders offer the potential for novel diagnostic methods that facilitate early and accurate diagnosis of patients.